KISQALI FEMARA CO-PACK (COPACKAGED) FDA approval date

The FDA approved KISQALI FEMARA CO-PACK (COPACKAGED) on 4 May 2017.

FDA approval date
4 May 2017

Drug identity has not yet been verified against registry records

Also recorded as LETROZOLE; RIBOCICLIB SUCCINATE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2017-05-04DayKISQALI FEMARA CO-PACK (COPACKAGED)FDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA209935", "applicant_as_listed_by_fda": "NOVARTIS", "brand_names": ["KISQALI FEMARA CO-PACK (COPACKAGED)"], "active_ingredients": ["LETROZOLE", "RIBOCICLIB SUCCINATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20170504", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026